Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 266-564-7 | CAS number: 67075-37-0
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Genetic toxicity in vitro
Description of key information
Ames-Test: negative, according to OECD TG 471 and 472, GLP compliant, Salmonella typhimurium strains: TA 98, TA 100, TA 1535 and TA 1537 and Escherichia coli strain WP2, with and without metabolic activation, 1991, K1
HPRT: Read-across, negative, according to OECD TG 476, GLP compliant, Chinese hamster lung fibroblasts (V79), with and without metabolic activation, 2012, K1
Chromosome aberration test: negative, according to OECD TG 473, GLP compliant, Chinese hamster ovary cells (CHO), with and without metabolic activation, 1989, K1
Link to relevant study records
- Endpoint:
- in vitro gene mutation study in mammalian cells
- Type of information:
- read-across based on grouping of substances (category approach)
- Adequacy of study:
- key study
- Justification for type of information:
- see attached justification
- Reason / purpose for cross-reference:
- read-across source
- Species / strain:
- Chinese hamster Ovary (CHO)
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity, but tested up to precipitating concentrations
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- True negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Endpoint:
- in vitro gene mutation study in mammalian cells
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 04 May 2020 - 13 Jul 2020
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 476 (In Vitro Mammalian Cell Gene Mutation Test using the Hprt and xprt genes)
- Version / remarks:
- 29 Jul 2016
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.17 (Mutagenicity - In Vitro Mammalian Cell Gene Mutation Test)
- Version / remarks:
- 30 May 2008
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.5300 - In vitro Mammalian Cell Gene Mutation Test
- Version / remarks:
- Aug 1998
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- in vitro mammalian cell gene mutation test using the Hprt and xprt genes
- Specific details on test material used for the study:
- Batch identification: 100071P040
CAS No.: 4948-15-6
Content: Sum.: 99.7 g/100 g
Date of production: 21 Dec 2010
Date of expiry: 30 Mar 2023
Molecular weight: 598.66 g/mol
Physical state, appearance: Solid, orange-red
Mass-specific surface area (BET): 97.1 m²/g
Storage conditions: Room temperature
Homogeneity: The homogeneity of the test substance was ensured by mixing before preparation of the test substance preparations.
Storage stability: The stability of the test substance under storage conditions was guaranteed until 30 Mar 2023 as indicated by the sponsor, and the sponsor holds this responsibility. - Target gene:
- hprt
- Species / strain / cell type:
- Chinese hamster Ovary (CHO)
- Details on mammalian cell type (if applicable):
- CELLS USED
- Type and source of cells: CHO (Chinese hamster ovary)
- Suitability of cells: not specified
For cell lines:
- Absence of Mycoplasma contamination: each batch checked
- Number of passages if applicable: at least 2 passages before experiment; a further passage to prepare test cultures
- Methods for maintenance in cell culture: Cells were grown with 5% (v/v) CO2 at 37°C and ≥ 90% relative humidity up to approximate confluence and subcultured twice weekly (routine passage in 75 cm² plastic flasks).
- Cell cycle length, doubling time or proliferation index : high proliferation rate (doubling time of about 12 - 16 hours)
- Modal number of chromosomes: karyotype with a modal number of 20 chromosomes
- Periodically checked for karyotype stability: not specified
- Periodically ‘cleansed’ of spontaneous mutants: yes
MEDIA USED
- All media were supplemented with penicillin/streptomycin (100 IU / 100 μg/mL), amphotericine B (2.50 μg/mL)
- Culture medium/Treatment medium(without S9 mix): Ham's F12 medium with stable glutamine, hypoxanthine, 10% (v/v) fetal calf serum (FCS)
- Treatment medium (with S9 mix): Ham's F12 medium with stable glutamine, hypoxanthine
- Pretreatment medium ("HAT" medium): Ham's F12 medium with hypoxanthine (136 µg/mL), aminopterin (1.8 µg/mL), thymidine (38.8 µg/mL), 10% (v/v) FCS
- Selection medium ("TG" medium): Ham's F12 medium with stable glutamine, 6-thioguanine (10 μg/mL), 10% (v/v) FCS - Metabolic activation:
- with and without
- Metabolic activation system:
- Type and composition of metabolic activation system:
- source of S9
- method of preparation of S9 mix
- concentration or volume of S9 mix and S9 in the final culture medium
- quality controls of S9 (e.g., enzymatic activity, sterility, metabolic capability)
The S9 fraction was prepared according to Ames et al. (1975):
- At least 5 male Wistar rats [Crl:WI(Han)] (200 - 300 g; Charles River Laboratories Germany GmbH) received 80 mg/kg b.w. phenobarbital i.p. and β-naphthoflavone orally each on three consecutive days.
- During this time, the animals were housed in polycarbonate cages: central air conditioning with a fixed range of temperature of 20 - 24°C and a fixed relative humidity of 45 - 65%. The day/night rhythm was 12 hours: light from 6 am – 6 pm and darkness from 6 pm – 6 am. Standardized pelleted feed and drinking water from bottles were available ad libitum.
- 24 hours after the last administration, the rats were sacrificed and the livers were prepared using sterile solvents and glassware at a temperature of +4°C.
- The livers were weighed and washed in a weight-equivalent volume of a 150 mM KCl solution and homogenized in three volumes of KCl solution. After centrifugation of the homogenate at 9000 x g for 10 minutes at +4°C, 5 mL portions of the supernatant (S9 fraction) were stored at -70°C to -80°C.
- The S9 mix was prepared freshly prior to each experiment (Ames, 1975). For this purpose, a sufficient amount of S9 fraction was thawed at room temperature; 1 part S9 fraction was mixed with 9 parts S9 supplement (cofactors) in the pre-experiment and main experiments. This preparation, the S9 mix (10% S9 fraction), was kept on ice until used. The concentrations of the cofactors in the S9 mix were: 8 mM MgCl2, 33 mM KCL, 5 mM glucose-6-phosphate, 4 mM NADP, 15 mM phosphate buffer (pH 7.4).
- The phosphate buffer (DeMarini, 1989) is prepared by mixing a Na2HPO4 solution with a NaH2PO4 solution in a ratio of about 4:1.
Ames, B.N. et al. (1975): Methods for detecting carcinogens and mutagens with the Salmonella/mammalian microsome mutagenicity test. Mut. Res. 31, 347-364.
DeMarini, D.M. et al. (1989): Cytotoxicity and effect on mutagenicity of buffers in a microsuspension assay. Ter. Carc. Mut. 9, 287-295. - Test concentrations with justification for top dose:
- Based on the data and the observations from the pre-test and taking into account the current
guidelines, the following doses were selected in this study:
Dose selection (with and without S9 mix), 4 h exposure: 0.05, 0.08, 0.15, 0.26, 0.48, 0.86, 1.54, 2.78, 5.00 µg/mL
The highest tested concentration (5.00 μg/mL) was based on test substance precipitation in culture medium. - Vehicle / solvent:
- Due to the insolubility of the test substance in culture medium, acetone was selected as the vehicle, which had been demonstrated to be suitable in the CHO/HPRT assay and for which historical data are available. The final concentration of the vehicle acetone in culture medium was 1% (v/v).
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- 7,12-dimethylbenzanthracene
- ethylmethanesulphonate
- Details on test system and experimental conditions:
- Time schedule:
- Day 1: Seeding of the cells pretreated with "HAT" medium: in 300 cm² flasks (20x10^6 cells in 40 mL)
- Day 2: Test substance incubation (20 – 24 hours after seeding); exposure period (4 hours); removal of test substance by intense washing; 1st passage of the treated cells in 175 cm² flasks (2x10^6 cells in 20 mL medium) and seeding of the cloning efficiency 1 (survival) in 60 mm petri dishes (200 cells in 5 mL medium).
- Day 5: 2nd passage of the treated cells (seeding of 2x10^6 cells in 20mL medium)
- Day 7 - 9: Drying, fixation, staining and counting of the cloning efficiency 1; 3rd passage of the treated cells; addition of selection medium ("TG" medium); and seeding of the cloning efficiency 2 (viability)
- From day 16: Drying, fixation, staining and counting of the selected colonies and cloning efficiency 2
NUMBER OF REPLICATIONS:
- Number of cultures per concentration: 2
- Number of independent experiments: 1
METHOD OF TREATMENT/ EXPOSURE:
- Cell density at seeding (if applicable): 20x10^6 cells in 40 mL
- Test substance added in medium
TREATMENT AND HARVEST SCHEDULE:
- Attachment period of the cells: 20 - 24 hours
- Exposure duration/duration of treatment: 4 hours
FOR GENE MUTATION:
- Expression time: 7-9 days (from day 2)
- Selection time: 6-7 days (from day 7 to 9)
- Selective agent: 6-thioguanine (10 μg/mL)
- Fixation time: from day 7-9 and 16
- Each test group were fixed with methanol, stained with Giemsa and counted.
METHODS FOR MEASUREMENT OF CYTOTOXICITY
- Cloning efficiency 1: For the determination of the influence of the test substance after the exposure period, 200 cells per concentration were reserved from the treated cells and were seeded in petri dishes (60 mm diameter) and coated with 5 mL Ham's F12 medium incl. 10% (v/v) FCS in parallel to the 1st passage directly after test substance incubation.
- Cloning efficiency 2: For the determination of the mutation rate after the expression period, two aliquots of 200 cells each were reserved from the transfer into selection medium (after 7 – 9 days) and seeded in two petri dishes (60 mm diameter) containing 5 mL Ham's F12 medium incl. 10% (v/v) FCS.
- In all cases, after seeding the flasks or petri dishes were incubated for 5 - 8 days to form colonies. These colonies were fixed, stained and counted.
The cloning efficiency (CE, %) was calculated for each test group as follows:
total number of colonies in the test group
CEabsolute = ————————————————————— x 100
total number of seeded cells in the test group
CEabsolute of the test group
CErelative = —————————————— x 100
CEabsolute of the vehicle control
The number of colonies in every petri dish was counted and recorded. Using the formula above the values of absolute cloning efficiencies (CEabsolute, CE1 absolute and/or CE2 absolute) were calculated. Based on these values the relative cloning efficiencies (CErelative, CE1 relative and/or CE2 relative) of the test groups were calculated and reported as a percentage of the respective CEabsolute value of the corresponding vehicle control (vehicle control = 100%).
In addition, with regard to cell loss while exposure period, relative survival (RS) is calculated based on CE of cells plated immediatedly after treatment adjusted by any loss of cells during treatment as compared with adjusted cloning efficiency in vehicle controls.
number of cells at the end of treatment
Adjusted CE = —————————————————— x CE1
number of seeded cells
adjusted CE of the test group
RS = ———————————————————— x 100
adjusted CE of the vehicle control
METHODS FOR MEASUREMENTS OF GENOTOXICIY
The number of colonies in each flask was counted and recorded. The sum of the mutant colony counts within each test group was subsequently normalized per every 10^6 cells seeded. The uncorrected mutant frequency (MFuncorr.) per 10^6 cells was calculated for each test group as follows:
total number of mutant colonies
MFuncorr. = —————————————–— x 10^6
number of seeded cells
The uncorrected mutant frequency was corrected with the absolute cloning efficiency 2 for each test group to get the corrected mutant frequency (MFcorr.):
MFuncorr.
MFcorr. = —–——–— x 100
CE2 absolute
OTHER:
- Check or determination of further parameters: pH, osmolality, solubility, cell morpology - Evaluation criteria:
- Acceptance criteria:
- The HPRT assay is considered valid if the following criteria are met:
• The absolute cloning efficiencies of the vehicle controls should not be less than 50% (with and without S9 mix).
• The background mutant frequency in the vehicle controls should be within our historical negative control data range (95% control limit). Weak outliers can be judged acceptable if there is no evidence that the test system is not “under control”.
• Concurrent positive controls both with and without S9 mix should induce responses that are compatible with those generated in the historical positive control data base and produce a statistically significant increase in mutant frequencies compared with the concurrent vehicle control.
Assessment criteria:
- A test substance is considered to be clearly positive if all following criteria are met:
• A statistically significant increase in mutant frequencies is obtained.
• A dose-related increase in mutant frequencies is observed.
• The corrected mutation frequencies (MFcorr.) exceeds both the concurrent vehicle control value and the range of our laboratory’s historical negative control data (95% control limit).
- Isolated increases of mutant frequencies above our historical negative control range or isolated statistically significant increases without a dose-response relationship may indicate a biological effect but are not regarded as sufficient evidence of mutagenicity.
- A test substance is considered to be clearly negative if the following criteria are met:
• Neither a statistically significant nor dose-related increase in the corrected mutation
frequencies is observed under any experimental condition.
• The corrected mutation frequencies in all treated test groups is close to the concurrent
vehicle control value and within the range of our laboratory’s historical negative control data
(95% control limit). - Statistics:
- A linear dose-response was evaluated by testing for linear trend. The dependent variable was the corrected mutant frequency and the independent variable was the dose.
The calculation was performed using EXCEL function RGP.
The used model is one of the proposed models of the International Workshop on Genotoxicity
Test procedures Workgroup Report (Moore, 2003).
A pair-wise comparison of each test group with the control group was carried out using Fisher's exact test with Bonferroni-Holm correction (Holm, 1979 and Siegel, 1956). The calculation was performed using EXCEL function HYPGEOM.VERT.
If the results of these tests were statistically significant compared with the respective vehicle control, labels (s p ≤ 0.05) are printed in the tables.
However, both, biological and statistical significance are considered together.
- Moore, M.M. et al. (2003) Mouse Lymphoma Thymidine Kinase Gene Mutation Assay: International Workshop on Genotoxicity Tests (IWGT) Workgroup Report – Plymouth, UK 2002. Mut. Res. 540, 127–140.
- Holm, S. (1979) A Simple Sequentially Rejective Multiple Test Procedure. Scand J Statist 6, 65-70.
- Siegel, S. (1956) Nonparametric statistics for the behavioral sciences. New York, NY, US: McGraw-Hill - Species / strain:
- Chinese hamster Ovary (CHO)
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity, but tested up to precipitating concentrations
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- True negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Additional information on results:
- TEST-SPECIFIC CONFOUNDING FACTORS
- Data on pH: not affected
- Data on osmolality: not affected
- Possibility of evaporation from medium: no
- Water solubility: insoluble in water and cell culture medium
- Precipitation and time of the determination: test substance precipitation was observed at 1.25 μg/mL and above after 4 hours in the absence and presence of S9 mix
- Cell morphology and attachment of the cells: not adversely influenced (grade > 2) in any test group
RANGE-FINDING/SCREENING STUDIES:
An initial range-finding cytotoxicity test for the determination of the experimental doses was conducted.
The pre-test was performed following the method described for the main experiment. The relative survival (RS) was determined as a toxicity indicator for dose selection and various parameters were checked for all, or at least some, selected doses.
In the pre-test for toxicity based on the solubility properties of the test substance 10.00 μg/mL (approx. 0.02 mM) was used as top concentration both with and without S9 mix at 4 hour exposure time.
STUDY RESULTS
- The mutation frequencies of the vehicle control groups were within our historical negative control data range (95% control limit) and, thus, fulfilled the acceptance criteria of this study.
- The increase in the frequencies of mutant colonies induced by the positive control substances EMS and DMBA clearly demonstrated the sensitivity of the test method and/or of the metabolic activity of the S9 mix employed.
For all test methods and criteria for data analysis and interpretation:
- At least four concentrations were evaluated to describe a possible dose response relationship.
- Statistical analysis; statistical significance for p ≤ 0.05
- see table 1 in section "Any other information on results incl. tables"
Gene mutation tests in mammalian cells:
- Results from cytotoxicity measurements and genotoxicity results: see table 2 in section "Any other information on results incl. tables"
HISTORICAL CONTROL DATA
please see table 3 and 4 in section "Any other information on results incl. tables" - Conclusions:
- Under the experimental conditions of this study, the test substance is not mutagenic in an in vitro mammalian cell gene mutation test (HPRT-locus) in absence and in the presence of metabolic activation.
- Executive summary:
The test substance was evaluated for genotoxic potential in a HPRT locus assay using CHO cells according to OECD TG 476 (GLP compliant). In one experiment a dose range from 0.05 to 5 µg/ml was tested, both with and without the addition of liver S9 mix from phenobarbital and β-naphthoflavone induced rats. Based on the results of the present study, the test substance did not cause any biologically relevant increase in the mutant frequencies either without or after the addition of the metabolizing system (S9 mix). No cytotoxicity could be observed, but a precipitation of the test materials was seen after 4 h exposure at dose 1.54 and above. Overall, the test item was considered to be non-mutagenetic under the conditions of the test.
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 472 (Genetic Toxicology: Escherichia coli, Reverse Mutation Assay)
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.13/14 (Mutagenicity - Reverse Mutation Test Using Bacteria)
- GLP compliance:
- yes
- Type of assay:
- bacterial reverse mutation assay
- Specific details on test material used for the study:
- - Physical state: black powder
- Analytical purity: 99 %
- Storage condition of test material: room temperature
- Lot/batch No.: 96-2363 - Target gene:
- his, trp
- Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98, TA 100 and E. coli WP2
- Metabolic activation:
- with and without
- Metabolic activation system:
- Aroclor 1254 induced rat liver S-9 mix
- Test concentrations with justification for top dose:
- 20, 100, 500, 2500, 5000 µg/plate
- Vehicle / solvent:
- DMSO
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- other: N-methyl-N-nitro-N-nitrosoguanidine
- Remarks:
- without S9 mix: TA100 and TA1535
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- other: 4-nitro-o-phenylendiamine
- Remarks:
- without S9 mix: TA98
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- 9-aminoacridine
- Remarks:
- without S9 mix: TA1537
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- N-ethyl-N-nitro-N-nitrosoguanidine
- Remarks:
- without S9 mix: E. coli WP2 uvrA
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- other: 2-aminoanthracene
- Remarks:
- with S9 mix
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: in agar (plate incorporation); preincubation
DURATION
Plate incorporation method:
- Exposure duration: ca. 48 hours at 37°C
Preincubation method:
- Preincubation period: 30 minutes at 30°C
- Exposure duration: 48 hours at 37°C
NUMBER OF REPLICATIONS:
- 3 test plates per dose or per control
DETERMINATION OF CYTOTOXICITY
reduced his- or trp- background growth - Evaluation criteria:
- In general, a substance to be characterized as positive in the bacterial tests has to fulfill the following requirements:
- doubling of the spontaneous mutation rate ( control)
- dose-response relationship
- reproducibility of the results - Species / strain:
- S. typhimurium TA 1535, TA 1537, TA 98, TA 100 and E. coli WP2
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- TEST-SPECIFIC CONFOUNDING FACTORS
- Precipitation: from about 2500 µg/plate onward - Conclusions:
- According to the results of the present study, the test substance is not mutagenic in the Ames test and in the Escherichia coli reverse mutation assay under the experimental conditions chosen here.
- Executive summary:
The test item was tested in a GLP compliant Ames reverse mutation assay (according to OECD guidelines 471 and 472) using Salmonella typhimurium strains TA98, TA100, TA1535 and TA1537 and Escherichia coli WP2 uvrA at 20 to 5000 µg/plate with and without metabolic activation using DMSO as the vehicle. In the toxicity test, the test compound proved to be not toxic to the bacteria up to 5000 µg/plate. Incomplete solubility of the test substance in DMSO was observed from about 2500 µg/plate onward. In the absence of the metabolic activation system the test compound did not show a dose dependent increase in the number of revertants in any of the bacterial strains. Also in the presence of the metabolic activation system, treatment of the cells with test material did not resultant in relevant increases in the number of revertant colonies. Under the conditions tested, the test article is not mutagenic in bacteria.
- Endpoint:
- in vitro cytogenicity / chromosome aberration study in mammalian cells
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 473 (In Vitro Mammalian Chromosome Aberration Test)
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.10 (Mutagenicity - In Vitro Mammalian Chromosome Aberration Test)
- Qualifier:
- according to guideline
- Guideline:
- other: Toxicity Test Guideline, (Japan) 1984
- GLP compliance:
- yes
- Type of assay:
- in vitro mammalian chromosome aberration test
- Specific details on test material used for the study:
- - Physical state: black powder
- Analytical purity: 99 %
- Storage condition of test material: room temperature
- Lot/batch No.: 96-2363 - Species / strain / cell type:
- Chinese hamster Ovary (CHO)
- Metabolic activation:
- with and without
- Metabolic activation system:
- Aroclor 1254 induced S-9 liver microsomal fraction
- Test concentrations with justification for top dose:
- without and with S9 mix:
7 h : 1.0 ; 5.0* ; 10.0* ; 20.0* μg/ml
24 h : 0.1 ; 0.5 ; 1.0 ; 5.0* ; 10.0* ; 20.0* μg/ml
30 h : 1.0 ; 5.0* ; 10.0* ; 20.0* μg/ml
(* precipitation of the test compound in the culture medium during incubation and not evaluated) - Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: DMSO
- Justification for choice of solvent/vehicle: The solvent was chosen according to its solubility properties and its relative non-toxicity for the cells. The final concentration of the solvent in the culture medium did not exceed 1 % v/v. - Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- ethylmethanesulphonate
- Remarks:
- without S9 mix Migrated to IUCLID6: final Concentration : 0.72 mg/ml = 5.76 mM
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- cyclophosphamide
- Remarks:
- with S9 mix Migrated to IUCLID6: final Concentration: 4.20 μg/ml = 15.00 μM
- Details on test system and experimental conditions:
- PRE-EXPERIMENT FOR TOXICITY: The toxicity of the test compound was determined in a pre-experiment (0.1 - 50 µg/ml) in order to establish a concentration dependent plating efficiency relationship. The experimental conditions in this pre-experiment were the same as described below for the experiment.
DOSE SELECTION
According to the results from this pre-experiment at least six concentrations to be applied in the chromosomal aberration assay were chosen.
The highest dose level used was 10 mM unless limited by the solubility of the test article or that producing some indication of cytotoxicity (reduced plating efficiency and/or partial inhibition of mitosis).
In case of toxic effects the highest dose level should reduce if possible the plating efficiency if possible to approximately 20 - 50 %. In addition, this concentration should suppress if possible mitotic activity (% cells in mitosis) by approximately 50 %, but not so great a reduction that insufficient scorable mitotic cells can be found.
Treatment was performed with the following concentrations:
without and with S9 mix:
7 h : 1.0 ; 5.0* ; 10.0* ; 20.0* μg/ml
24 h : 0.1 ; 0.5 ; 1.0 ; 5.0* ; 10.0* ; 20.0* μg/ml
30 h : 1.0 ; 5.0* ; 10.0* ; 20.0* μg/ml
(* precipitation of the test compound in the culture medium during incubation).
According to the criteria mentioned above, one (7, 30 h) and three concentrations (24 h) were selected to evaluate metaphases for cytogenetic damage.
In the pre-experiment for toxicity the colony forming ability of the CHO cells was only slightly reduced after treatment with 1.0 μg/ml in the presence of S9 mix. However, higher concentrations precipitated in the culture medium during incubation.
In the main experiment, cells after treatment with 1.0 μg/mL as highest dose level could be evaluated for cytogenetic damage. With these concentrations applied in the absence and presence of S9 mix the mitotic index was suppressed.
EXPERIMENTAL PERFORMANCE:
METHOD OF APPLICATION: in medium;
Seeding of the Cultures: Two days old logarithmically growing stock cultures more than 50 % confluent were trypsinised and a single cell suspension
was prepared. The trypsin concentration was 0 .2 % in Ca-Mg-free salt solution.
The cells were seeded into Quadriperm dishes (Heraeus, Hanau, D.) which contained microscopic slides (2 chambers per dish and test group). The medium was DMEM/F12 (1 :1) + 10 % FCS.
Approximately 0.6 - 1.5 x 10 5 cells were seeded into each chamber with regard to fixation interval.
After 48 h the medium was replaced with serum-free medium containing the test compound, either without S9 mix or with 20 μl/ml S9 mix. After 4 h this medium was replaced with normal medium after rinsing twice with "saline G".
All incubations were done at 37° C in a humidified atmosphere with 11.0 % CO2.
5, 21, 27 h after start of the treatment spindle inhibitor is added to the cultures. 2.0 h (7 h interval) or 3.0 h later (24 h and 30 h interval) the cells on the slides in the chambers were treated with hypotonic solution (0.4 % KCl) at 37 °C for 20 min. After incubation in the hypotonic solution the cells were fixed with 3:1 absolute methanol:glacial acetic acid. All two slides per group were prepared. After fixation the cells were stained with giemsa.
NUMBER OF REPLICATIONS: 2
SPINDLE INHIBITOR (cytogenetic assays): colcimid (0.2 µg/ml culture medium).
ANALYSIS
- Analysis of Metaphase Cells: The slides were evaluated using NIKON microscopes with 100x oil immersion objectives. Gaps, breaks, fragments, deletions, exchanges and chromosomal disintegrations are recorded as structural chromosome aberrations.
NUMBER OF CELLS EVALUATED: At least 100 well spread metaphases per slide (200 per test group) were scored for cytogenetic damage on coded slides. Only metaphases with characteristic chromosome number of 20 ± 1 are included in the analysis.
DETERMINATION OF CYTOTOXICITY
- Method: mitotic index (% cells in mitosis) - Evaluation criteria:
- A test substance is classified as mutagenic if it induces either a significant dose-related increase in the number of structural chromosomal aberrations or a significant positive response for at least one of the test points.
A test article producing neither a significant dose-related increase in the number of structural chromosomal aberrations nor a significant positive response at any one of the test points is considered non-mutagenic in this system. - Statistics:
- A statistical evaluation of the results was not necessary to perform. The aberration rates of the test groups after treatment with the test article were in the range of the control values.
- Species / strain:
- Chinese hamster Ovary (CHO)
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- In the pre-experiment on toxicity (colony forming ability) in the presence of S9 mix after treatment with 1.0 μg/ml the colony forming ability was only slightly reduced. However, higher concentrations precipitated in the culture medium during incubation.
In the main experiment, the mitotic index was reduced after treatment with 1.0 μg/ml indicating that the substance had cytotoxic properties. - Conclusions:
- In the study described and under the experimental conditions reported, the test article did not induce structural chromosome aberrations as determined by the chromosomal aberration test in the CHO Chinese Hamster cell line and is therefore considered to be non-mutagenic in this chromosomal aberration test.
- Executive summary:
The test article was assessed for its potential to induce structural chromosome aberrations in CHO cells in vitro. Preparation of chromosomes was done 7 h (high dose), 24 h (low, medium and high dose) and 30 h (high dose) after start of treatment with the test article. The treatment interval was 4 h. In each experimental group two parallel cultures were used. Per culture 100 metaphases were scored for structural chromosomal aberrations. The following dose levels were evaluated with and without S9 mix: 7 h: 1.0 μg/ml; 24 h: 0.1; 0.5; 1.0 μg/ml; 30 h: 1.0 μg/ml. The concentration range of the test article applied had been determined in a pre-experiment using the plating efficiency assay as indicator for toxicity response. Treatment of the cells with 1.0 µg/ml reduced only slightly the plating efficiency. Higher concentrations than 1.0 µg/ml precipitated in the culture medium during incubation. However, the mitotic index was reduced with the highest concentration in the absence and presence of S9 mix. There was no relevant increase in cells with structural aberrations after treatment with the test article at any fixation interval either without or with metabolic activation by S9 mix. Appropriate reference mutagens were used as positive controls and showed distinct increases of cells with structural chromosome aberrations.
Therefore, the test article is considered to be non-mutagenic in this chromosomal aberration test.
Referenceopen allclose all
Table 1: Linear trend-test
Linear trend-test | Slope* | One-sided p-value* |
Corrected Mutation frequency without S9 mix | -0.71162 | 0.7360 |
Corrected Mutation frequency with S9 mix | -1.32571 | 0.8616 |
* The linear trend-test testing for an increased mutant frequency is significant (significance level of 5%), if the one-sided p-value is lower than 0.05 and the slope is greater than 0.
Table 2: Summary of results
Exp. | Exposure period | Test groups | S9 | Prec.* | Genotoxicity** | Cytotoxicity*** | |
| [h] | [µg/mL] |
|
| [per 106 cells] | RS [%] | CE2 [%] |
1 | 4 | VC1 | - | n.d. | 1.05 | 100.0 | 100.0 |
|
| 0.05 | - | - | n.c. | 125.6 | n.c. |
|
| 0.08 | - | - | n.c. | 134.3 | n.c. |
|
| 0.15 | - | - | n.c. | 135.3 | n.c. |
|
| 0.26 | - | - | 3.39 | 128.5 | 103.5 |
|
| 0.48 | - | - | 0.00 | 124.5 | 135.8 |
|
| 0.86 | - | - | 0.68 | 132.5 | 103.5 |
|
| 1.54 | - | + | 0.61 | 128.7 | 114.7 |
|
| 2.78 | - | + | n.c.1 | n.c.1 | n.c.1 |
|
| 5.00 | - | + | n.c.1 | n.c.1 | n.c.1 |
|
| PC2 | - | n.d | 42.12s | 113.2 | 102.5 |
1 | 4 | VC1 | + | n.d. | 1.42 | 100.0 | 100.0 |
|
| 0.05 | + | - | n.c. | 91.9 | n.c. |
|
| 0.08 | + | - | n.c. | 89.1 | n.c. |
|
| 0.15 | + | - | n.c. | 103.8 | n.c. |
|
| 0.26 | + | - | 3.13 | 107.9 | 102.5 |
|
| 0.48 | + | - | 1.69 | 68.1 | 105.3 |
|
| 0.86 | + | - | 1.53 | 96.1 | 92.9 |
|
| 1.54 | + | + | 0.72 | 82.6 | 98.9 |
|
| 2.78 | + | + | n.c.1 | n.c.1 | n.c.1 |
|
| 5.00 | + | + | n.c.1 | n.c.1 | n.c.1 |
|
| PC3 | + | n.d. | 48.52s | 72.6 | 84.3 |
* Microscopically visible precipitation in culture medium at the end of exposure period
** Mutant frequency MFcorr.: mutant colonies per 106 cells corrected with the CE2 value
*** Cloning efficiency related to the respective vehicle control
s Mutant frequency statistically significantly higher than corresponding control values (p ≤ 0.05)
n.c. Culture was not continued since a minimum of only four analysable concentrations is required
n.c.1 Culture was not continued since only one concentration beyond the solubility limit is required
n.d. Not determined
VC vehicle control
PC positive control
1 Acetone 1% (v/v) 2 EMS 400 μg/mL 3 DMBA 1.25 μg/mL
Table 3: HISTORICAL NEGATIVE CONTROL DATA
Summary (all vehicles)
Period: March 2016 - December 2019
| Without S9 mix all vehicles* | With S9 mix all vehicles* |
Corrected Mutant Frequency** | ||
Exposure period | 4 hrs | 4 hrs |
Mean | 2.76 | 2.93 |
Minimum | 0.00 | 0.00 |
Maximum | 8.00 | 9.93 |
Standard Deviation | 1.73 | 2.09 |
95% Lower Control Limit | 0.00 | 0.00 |
95% Upper Control Limit | 6.21 | 7.08 |
No. of Experiments | 130 | 132 |
* = culture medium, water 10% (v/v), DMSO 1% (v/v), acetone 1% (v/v)
** = mutant frequency (per 1 million cells) corrected with the cloning efficiency at the end of the expression period (CE2)
Table 4: HISTORICAL POSITIVE CONTROL DATA
Summary (all vehicles)
Period: March 2016 - December 2019
| Without S9 mix 400 µg/mL ethyl methanesulfonate (EMS) | With S9 mix 1.25 µg/mL 7,12-Dimethylbenz[a]anthracene (DMBA) |
| Corrected Mutant Frequency* | Corrected Mutant Frequency* |
Exposure period | 4 hrs | 4 hrs |
Mean | 160.94 | 126.62 |
Minimum | 42.47 | 21.52 |
Maximum | 438.29 | 270.48 |
Standard Deviation | 73.52 | 54.78 |
No. of Experiments | 124 | 129 |
* = mutant frequency (per 1 million cells) corrected with the cloning efficiency at the end of the expression period (CE2)
Standard Plate Test Result:
TA 1535 | TA 100 | TA 1537 | TA 98 | WP2uvrA | ||||||
Dose (µg/plate) | -S9 | +S9 | -S9 | +S9 | -S9 | +S9 | -S9 | +S9 | -S9 | +S9 |
0 | 10 | 12 | 88 | 102 | 10 | 10 | 27 | 35 | 36 | 47 |
20 | 10 | 13 | 92 | 115 | 11 | 12 | 22 | 35 | 26 | 39 |
100 | 9 | 13 | 74 | 98 | 9 | 10 | 31 | 33 | 29 | 38 |
500 | 15 | 8 | 67 | 94 | 9 | 10 | 29 | 40 | 33 | 37 |
2500 | 14 | 12 | 90 | 102 | 9 | 9 | 26 | 38 | 29 | 34 |
5000 | 12 | 16 | 77 | 92 | 9 | 12 | 26 | 41 | 36 | 34 |
2-AA | 320 | 908 | 121 | 2350 | 173 | |||||
MNNG | 1336 | 1327 | ||||||||
AAC | 463 | |||||||||
NPD | 1817 | |||||||||
ENNG | 199 |
Preincubation Test Result:
TA 1535 | TA 100 | TA 1537 | TA 98 | WP2uvrA | ||||||
Dose (µg/plate) | -S9 | +S9 | -S9 | +S9 | -S9 | +S9 | -S9 | +S9 | -S9 | +S9 |
0 | 17 | 18 | 116 | 113 | 11 | 11 | 29 | 35 | 22 | 24 |
20 | 17 | 15 | 123 | 120 | 9 | 10 | 24 | 39 | 25 | 28 |
100 | 16 | 18 | 97 | 119 | 9 | 10 | 27 | 42 | 26 | 27 |
500 | 20 | 18 | 79 | 107 | 10 | 12 | 28 | 40 | 23 | 30 |
2500 | 14 | 17 | 85 | 89 | 10 | 10 | 21 | 40 | 25 | 30 |
5000 | 16 | 15 | 69 | 81 | 12 | 10 | 22 | 37 | 22 | 24 |
2-AA | 151 | 661 | 109 | 1137 | 127 | |||||
MNNG | 879 | 897 | ||||||||
AAC | 230 | |||||||||
NPD | 1067 | |||||||||
ENNG | 399 |
Controls:
2-AA: 2-aminoanthracene (10 µg/plate for TA strains, 60 µg/plate for WP2uvrA)
MNNG: N-methyl-N'-nitro-N-nitrosoguanidine (5 µg/plate)
AAC: 9-aminoacridine (100 µg/plate)
NPD: 4-nitro-o-phenylendiamine (10 µg/plate)
ENNG: N-ethyl-N'-nitro-N-nitrosoguanidin (10 µg/plate)
Summarv of results
Fixation Interval: 7 h | % aberrant cells | |||||
article | number of cells analyzed | concentration /ml | S9-Mix | incl. Gaps | excl. Gaps | exchanges |
solvent control | 200 | 0 | - | 0.5 | 0 | 0 |
test article | 200 | 1 | - | 3.5 | 2.5 | 0.5 |
solvent control | 100* | 0 | + | 7 | 4 | 1 |
test article | 100* | 1 | + | 8 | 4 | 0 |
Fixation Interval: 24 h | % aberrant cells | |||||
article | number of cells analyzed | concentration /ml | S9-Mix | incl. Gaps | excl. Gaps | exchanges |
negative control | 200 | 0 | - | 2.5 | 2.5 | 1 |
solvent control | 200 | 0 | - | 0.5 | 0 | 0 |
positive control EMS | 200 | 0.72 | - | 26.5 | 23.5 | 12.5 |
test article | 200 | 0.1 | - | 1.5 | 1 | 0.5 |
test article | 200 | 0.5 | - | 4 | 2.5 | 0.5 |
test article | 200 | 1 | - | 4 | 3 | 0 |
negative control | 200 | 0 | + | 4.5 | 4 | 1.5 |
solvent control | 100* | 0 | + | 9 | 5 | 2 |
positive control CPA | 200 | 4.2 | + | 15 | 10.5 | 8 |
test article | 200 | 0.1 | + | 9.5 | 5 | 1.5 |
test article | 200 | 0.5 | + | 5 | 2.5 | 0.5 |
test article | 200 | 1 | + | 7 | 2 | 0 |
1 | ||||||
Fixation Interval: 24 h | % aberrant cells | |||||
article | number of cells analyzed | concentration /ml | S9-Mix | incl. Gaps | excl. Gaps | exchanges |
solvent control | 200 | 0 | - | 4.5 | 1 | 0 |
test article | 200 | 1 | - | 4.5 | 2.5 | 0.5 |
solvent control | 200 | 0 | + | 4 | 3.5 | 1 |
test article | 200 | 1 | + | 7.5 | 4 | 1.5 |
*one slide out of two was not scorable
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Genetic toxicity in vivo
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
Bacterial Mutagenicity
The test item was tested in a GLP compliant Ames reverse mutation assay (according to OECD guidelines 471 and 472) using Salmonella typhimurium strains TA98, TA100, TA1535 and TA1537 and Escherichia coli WP2 at 20 to 5000 µg/plate with and without metabolic activation using DMSO as the vehicle (BASF AG, 1991). In the toxicity test, the test compound proved to be not toxic to the bacteria up to 5000 µg/plate. Incomplete solubility of the test substance in DMSO was observed from about 2500 µg/plate onward. In the absence of the metabolic activation system the test compound did not show a dose dependent increase in the number of revertants in any of the bacterial strains. Also in the presence of the metabolic activation system, treatment of the cells with test material did not resultant in relevant increases in the number of revertant colonies. Under the conditions tested, the test article is not mutagenic in bacteria.
In a second, supporting Ames reverse mutation assay (study comparable to OECD guideline 471) the test article was tested using Salmonella typhimurium strains TA98, TA100, TA1535, TA1537 and TA1538 at 1 to 5000 µg/plate (vehicle: DMSO) with and without metabolic activation (BASF AG, 1985). The test material was not mutagenic in any of the S. typhimurium strains. Under the conditions tested, the test article is not mutagenic in the Ames test.
Mammalian Mutagenicity
As no data for the test substance is available regarding mutagenicity in mammalian cells a read-across to the category member CAS 4948-15-6 was performed.
The test substance was evaluated for genotoxic potential in a HPRT locus assay using CHO cells according to OECD TG 476 with GLP compliance (BASF, 2020). In one experiment a dose range from 0.05 to 5 µg/ml was tested, both with and without the addition of liver S9 mix from phenobarbital and β-naphthoflavone induced rats. Based on the results of the present study, the test substance did not cause any biologically relevant increase in the mutant frequencies either without or after the addition of the metabolizing system (S9 mix). No cytotoxicity could be observed, but a precipitation of the test materials was seen after 4 h exposure at dose 1.54 and above. Overall, the test item was considered to be non-mutagenetic under the conditions of the test.
Chromosomal Damage
The test article was studied in a GLP-compliant in vitro mammalian chromosome aberration test with Chinese hamster ovary cells (CHO) following OECD guideline 473 (CCR, 1989). The treatment interval was 4 hours. Preparation of chromosomes was done 7 hours (1.0 µg/L), 24 hours (0.1, 0.5 and 1.0 µg/L) and 30 hours (1.0 µg/L) after start of treatment with the test article in absence and presence of S9-mix. Treatment of the cells with 1.0 μg/ml reduced only slightly the plating efficiency. Higher concentrations than 1.0 μg/ml precipitated in the culture medium during incubation. The mitotic index was reduced with the highest concentration in the absence and presence of S9-mix. There was no relevant increase in cells with structural aberrations after treatment with the test article at any fixation interval either without or with metabolic activation by S9-mix. Therefore, the substance is considered to be non-mutagenic in this chromosomal aberration test.
Further toxicological data of category members:
The test article belongs to the "perylene based organic pigments" category (see attached document for details on category members and for read across justification). Regarding the genetic toxicity, additional reliable data are available for other category members. All of the studies are taken into account for the evaluation and assessment of the toxicity of the test article.
At least one Ames tests per substance is available for all other category members. None of these tests gave any rise to concern for genotoxicity. Consequently, all substances of this category have been regarded as not genotoxic in the bacterial reverse mutation test.
The additional HPRT and CA assays, performed for other category members, each with and without metabolic activation, were also negative and lead no evidence for a mutagenic potential of the test substances.
Justification for classification or non-classification
Classification, Labelling, and Packaging Regulation (EC) No. 1272/2008
The available experimental test data are reliable and suitable for classification purposes under Regulation 1272/2008. No indication of genotoxicity was observed in the Ames test (OECD 471, GLP), the HPRT Test (OECD 476, GLP) and the in vitro chromosome aberration assay (OECD 473, GLP). As a result, the substance is not considered to be classified for mutagenicity under Regulation (EC) No. 1272/2008, as amended for the fourteenth time in Regulation (EC) No. 2020/217.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.